Citation Impact
Citing Papers
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non–Small Cell Lung Cancer Cells Resistant to Erlotinib
2007
Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023
2008
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Transplantation ofex vivoexpanded endothelial progenitor cells for therapeutic neovascularization
2000 Standout
HER-2/neu-Specific Monoclonal Antibodies Collaborate with HER-2/neu-Targeted Granulocyte Macrophage Colony-Stimulating Factor Secreting Whole Cell Vaccination to Augment CD8+ T Cell Effector Function and Tumor-Free Survival in Her-2/neu-Transgenic Mice
2003
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
2017 Standout
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Southwestern Internal Medicine Conference: Clinical Use of Hematopoietic Growth Factors
1993
Ovarian cancer staging: Does it require a gynecologic oncologist?
1992
Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
2001 Standout
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells
2001 Standout
Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo
2005 Standout
Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers
2003
Antibody‐dependent cellular cytotoxicity of cetuximab against tumor cells with wild‐type or mutant epidermal growth factor receptor
2007
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Lung Cancer
2008 Standout
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio
2010
Role of neutrophils in innate immunity: a systems biology‐level approach
2009
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
Standardization of Epidermal Growth Factor Receptor (EGFR) Measurement by Quantitative Immunofluorescence and Impact on Antibody-Based Mutation Detection in Non–Small Cell Lung Cancer
2011
Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy.
1992
Molecular mechanisms of cisplatin resistance
2011 Standout
Neutrophils in the activation and regulation of innate and adaptive immunity
2011 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Exploiting tumour hypoxia in cancer treatment
2004 Standout
Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
1996
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
2004 Standout
The regulation of E2F by pRB-family proteins
1998 Standout
Chemotherapy and the war on cancer
2005 Standout
Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03
2009
Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk
2003 Standout
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.
1990
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
The ubiquitin system: pathogenesis of human diseases and drug targeting
2004 StandoutNobel
Regulation of Vascularization by Hypoxia‐Inducible Factor 1
2009 StandoutNobel
Mechanisms of angiogenesis and arteriogenesis
2000 Standout
Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
2001 Standout
Functions and mechanisms of long noncoding RNAs in lung cancer
2016
Neutrophils in cancer: neutral no more
2016 Standout
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
2005 Standout
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization
1999 Standout
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
Angiogenesis as a therapeutic target
2005 StandoutNature
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
1999 Standout
Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
1992
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Cancer of the Ovary
2004 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
The role of cellular transcription factor E2F in the regulation of cdc2 mRNA expression and cell cycle control of human hematopoietic cells
1994
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.
2005
Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats
2001 Standout
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients
2009
p53 and HER2/neu Expression in Relation to Chemotherapy Response in Patients with Non-Small Cell Lung Cancer
2006
Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor
1989
Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease
2001 Standout
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)
2002 Standout
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
1997 Standout
Wound Healing: A Cellular Perspective
2018 Standout
Endothelial Progenitor Cells
2004 Standout
PADGE: analysis of heterogeneous patterns of differential gene expression
2007
What's your age again? Determination of human neutrophil half-lives revisited
2013
Works of C Mossetti being referenced
HER‐2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma
2002
Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor.
1989
Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer
2003
Cisplatin and cyclophosphamide in early epithelial ovarian carcinoma.
1987
GM-CSF: intravenous versus subcutaneous treatment.
1990